On Monday, Neurogene Inc (NASDAQ: NGNE) was -9.34% drop from the session before settling in for the closing price of $34.26. A 52-week range for NGNE has been $6.88 – $74.49.
Healthcare Sector giant saw their annual sales slid by -10.74% over the last five years. When this article was written, the company’s average yearly earnings per share was at -10.28%. With a float of $12.14 million, this company’s outstanding shares have now reached $14.27 million.
Neurogene Inc (NGNE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Neurogene Inc stocks. The insider ownership of Neurogene Inc is 14.93%, while institutional ownership is 97.86%. The most recent insider transaction that took place on May 14 ’25, was worth 103,003. In this transaction Chief Scientific Officer of this company sold 6,797 shares at a rate of $15.15, taking the stock ownership to the 20,794 shares. Before that another transaction happened on May 14 ’25, when Company’s Officer proposed sale 6,797 for $15.51, making the entire transaction worth $105,421.
Neurogene Inc (NGNE) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.19 earnings per share (EPS) during the time that was better than consensus figure (set at -1.22) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -23.39% during the next five years compared to -10.74% drop over the previous five years of trading.
Neurogene Inc (NASDAQ: NGNE) Trading Performance Indicators
You can see what Neurogene Inc (NGNE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 18.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.63, a number that is poised to hit -1.25 in the next quarter and is forecasted to reach -5.91 in one year’s time.
Technical Analysis of Neurogene Inc (NGNE)
Analysing the last 5-days average volume posted by the [Neurogene Inc, NGNE], we can find that recorded value of 0.25 million was better than the volume posted last year of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 71.01%.
During the past 100 days, Neurogene Inc’s (NGNE) raw stochastic average was set at 72.56%, which indicates a significant increase from 38.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.41 in the past 14 days, which was higher than the 1.88 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.74, while its 200-day Moving Average is $19.00. Now, the first resistance to watch is $32.62. This is followed by the second major resistance level at $34.18. The third major resistance level sits at $36.88. If the price goes on to break the first support level at $28.36, it is likely to go to the next support level at $25.66. Now, if the price goes above the second support level, the third support stands at $24.10.
Neurogene Inc (NASDAQ: NGNE) Key Stats
There are 14,272K outstanding shares of the company, which has a market capitalization of 443.29 million. As of now, sales total 930 K while income totals -75,140 K. Its latest quarter income was 0 K while its last quarter net income were -22,020 K.
